Abstract Archives of the RSNA, 2014
GIE031-b
Beyond the Whipple Resection: What the Radiologist Needs to Know about the Multimodality Imaging of Borderline Resectable, Locally Advanced, and Metastatic Pancreatic Adenocarcinomas
Education Exhibits
Presented in 2014
John Webster Gilbert MD, Presenter: Nothing to Disclose
Atul Bhanudas Shinagare MD, Abstract Co-Author: Nothing to Disclose
Jyothi Priya Jagannathan MD, Abstract Co-Author: Nothing to Disclose
Brian M Wolpin MD, Abstract Co-Author: Nothing to Disclose
Nikhil H. Ramaiya MD, Abstract Co-Author: Nothing to Disclose
Michael Hayden Rosenthal MD, PhD, Abstract Co-Author: Nothing to Disclose
- About 70% of patients with pancreatic cancer present with locally advanced or metastatic disease, and another 5-10% have borderline resectable cancer.
- These three classes of pancreatic cancer undergo distinct treatments and demand different areas of vigilance on the part of the radiologist.
- Neoadjuvant therapy for borderline resectable tumors is performed with goal of resection and potential cure; locally advanced and metastatic tumors are treated for local control and palliation.
- Review of normal anatomy of the pancreas and nearby structures relevant to staging with correlation on CT and MRI, including discussion of optimum imaging technique
- Review of TNM staging system for pancreatic adenocarcinoma (AJCC 7th ed)
- Overview of classes of non-resectable pancreatic cancer (borderline resectable, locally advanced, metastatic) and current staging methods
- Illustration of common and uncommon pathways of tumor spread and sites of metastases with multimodality imaging
- Discussion of treatment options defined by extent of disease, including roles of chemotherapy, molecular targeted therapy, and radiotherapy
- Case-based review of side effects, complications, and treatment response
http://abstract.rsna.org/uploads/2014/14012414/14012414_nrrl.pdf
Gilbert, J,
Shinagare, A,
Jagannathan, J,
Wolpin, B,
Ramaiya, N,
Rosenthal, M,
Beyond the Whipple Resection: What the Radiologist Needs to Know about the Multimodality Imaging of Borderline Resectable, Locally Advanced, and Metastatic Pancreatic Adenocarcinomas. Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL.
http://archive.rsna.org/2014/14012414.html